179 results match your criteria: "Netherlands Cancer Institute NKI[Affiliation]"
Patient Educ Couns
October 2021
Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health, Amsterdam, the Netherlands. Electronic address:
Objective: Providing a second opinion (SO) in oncology is complex, and communication during SOs remains poorly understood. This study aimed to systematically observe how patients and oncologists communicate about SO-specific topics (i.e.
View Article and Find Full Text PDFFront Surg
March 2021
Urology Department, University of Catania, Catania, Italy.
After radical prostatectomy (RP) or radiotherapy (RT) for prostate cancer, erectile dysfunction (ED) is the main complication next to urinary incontinence, affecting quality of life. The pathophysiology of ED after these treatments is believed to include neuropraxia causing reduced oxygenation and structural changes of the tissue in the corpora cavernosa. Next to the option of sparing the nerves during RP, research has been focusing on methods for penile rehabilitation after RP and RT, since it occurs often, even after nerve-sparing techniques were used.
View Article and Find Full Text PDFRadiother Oncol
May 2021
Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Center(+), GROW Research Institute, Maastricht, The Netherlands.
Background: Prophylactic cranial irradiation (PCI) was compared to observation in several randomized trials (RCTs), and a reduction greater than 50% was shown regarding the incidence of brain metastases (BM). However, none of these studies showed an improvement of overall survival (OS), possibly related to relatively small sample sizes and short follow-up. The aim of this meta-analysis was therefore to assess the impact of PCI on long term OS for stage III non-small cell lung cancer (NSCLC) compared to observation based on the pooled updated individual patient RCT data.
View Article and Find Full Text PDFCancers (Basel)
November 2020
Department of Psychosocial Research and Epidemiology (PSOE), Netherlands Cancer Institute (NKI), 1066 CX Amsterdam, The Netherlands.
Adolescent and young adult (AYA) cancer patients, aged 15-39 years at primary cancer diagnosis, form a distinct, understudied, and underserved group in cancer care. This study aimed to assess long-term trends in incidence, survival, and mortality of AYA cancer patients within the Netherlands. Data on all malignant AYA tumours diagnosed between 1990-2016 ( = 95,228) were obtained from the Netherlands Cancer Registry.
View Article and Find Full Text PDFEur J Cancer
December 2020
Department of Medical Oncology and Department of Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address:
Aim Of The Study: Patients with cancer might have an increased risk for severe outcome of coronavirus disease 2019 (COVID-19). To identify risk factors associated with a worse outcome of COVID-19, a nationwide registry was developed for patients with cancer and COVID-19.
Methods: This observational cohort study has been designed as a quality of care registry and is executed by the Dutch Oncology COVID-19 Consortium (DOCC), a nationwide collaboration of oncology physicians in the Netherlands.
Nat Commun
September 2020
Divisions of Oncogenomics, The Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
The androgen receptor (AR) is the master regulator of prostate cancer (PCa) development, and inhibition of AR signalling is the most effective PCa treatment. AR is expressed in PCa cells and also in the PCa-associated stroma, including infiltrating macrophages. Macrophages have a decisive function in PCa initiation and progression, but the role of AR in macrophages remains largely unexplored.
View Article and Find Full Text PDFLaryngoscope
February 2021
Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Objective: Treatment decision-making for patients with laryngeal cancer consists of a complex trade-off between survival and quality of life. For decision makers on coverage and guidelines, costs come in addition to this equation. Our aim was to perform a cost-effectiveness analysis of surgery (laryngectomy with or without radiotherapy) versus organ preservation (OP: radiotherapy, chemo- and/or bioradiation) in advanced laryngeal cancer patients from a healthcare perspective.
View Article and Find Full Text PDFActa Oncol
December 2020
Department of Medical Psychology, Amsterdam UMC, Amsterdam Public Health, Amsterdam, The Netherlands.
Background: Cancer patients increasingly seek second opinion (SO) consultations, but there is scarce empirical evidence to substantiate medical and psychological benefits for patients. This is the first study to examine patient- and oncologist-reported (1) motivations and expectations of patients to seek a SO, (2) the perceived medical outcome, and (3) psychological consequences of SOs over time (i.e.
View Article and Find Full Text PDFEur Radiol
December 2020
Department of Respiratory Medicine, The First Hospital of Changsha City, Changsha, China.
Objective: To develop a fully automated AI system to quantitatively assess the disease severity and disease progression of COVID-19 using thick-section chest CT images.
Methods: In this retrospective study, an AI system was developed to automatically segment and quantify the COVID-19-infected lung regions on thick-section chest CT images. Five hundred thirty-one CT scans from 204 COVID-19 patients were collected from one appointed COVID-19 hospital.
Semin Cancer Biol
July 2021
Department of Medical Imaging, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA, Nijmegen, the Netherlands; Department of Radiology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address:
Screening for breast cancer with mammography has been introduced in various countries over the last 30 years, initially using analog screen-film-based systems and, over the last 20 years, transitioning to the use of fully digital systems. With the introduction of digitization, the computer interpretation of images has been a subject of intense interest, resulting in the introduction of computer-aided detection (CADe) and diagnosis (CADx) algorithms in the early 2000's. Although they were introduced with high expectations, the potential improvement in the clinical realm failed to materialize, mostly due to the high number of false positive marks per analyzed image.
View Article and Find Full Text PDFOncologist
September 2020
Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Background: After 5 years of annual follow-up following breast cancer, Dutch guidelines are age based: annual follow-up for women <60 years, 60-75 years biennial, and none for >75 years. We determined how the risk of recurrence corresponds to these consensus-based recommendations and to the risk of primary breast cancer in the general screening population.
Subjects, Materials, And Methods: Women with early-stage breast cancer in 2003/2005 were selected from the Netherlands Cancer Registry (n = 18,568).
Biosensors (Basel)
May 2020
Department of Pediatric Gastroenterology, Amsterdam UMC, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands.
Fecal volatile organic compounds (VOC) reflect human and gut microbiota metabolic pathways and their interaction. VOC behold potential as non-invasive preclinical diagnostic biomarkers in various diseases, e.g.
View Article and Find Full Text PDFData Brief
June 2020
Dipartimento di Fisica e Astronomia "Ettore Majorana", Università degli Studi di Catania, Via S. Sofia, 64, 95123 Catania, Italy.
Radiology
May 2020
From OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Fetscherstr 74, PF 41, 01307 Dresden, Germany (A.Z., S. Leger, E.G.C.T., C.R., S. Löck); National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany (A.Z.); Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany (A.Z., S. Leger, E.G.C.T.); German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany (A.Z., S. Leger, E.G.C.T., C.R., S. Löck); Medical Physics Unit, McGill University, Montréal, Canada (M.V., I.E.N.); Image Response Assessment Team Core Facility, Moffitt Cancer Center, Tampa, Fla (M.A.A.); Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Harvard University, Boston, Mass (H.J.W.L.A.); Institute of Information Systems, University of Applied Sciences Western Switzerland (HES-SO), Sierre, Switzerland (V.A., A.D., H.M.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY (A.A.); Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, Md (S.A.); Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (S.A., A.R.); Center for Biomedical image Computing and Analytics (CBICA), University of Pennsylvania, Philadelphia, Pa (S.B., C.D., S.M.H., S.P.); Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (S.B., C.D., S.M.H., S.P.); Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (S.B.); Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen (UMCG), Groningen, the Netherlands (R.J.B., R.B., E.A.G.P.); Radiology and Nuclear Medicine, VU University Medical Centre (VUMC), Amsterdam, the Netherlands (R.B.); Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland (M.B., M.Guckenberger, S.T.L.); Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy (L.B., N.D., R.G., J.L., V.V.); Laboratoire d'Imagerie Translationnelle en Oncologie, Université Paris Saclay, Inserm, Institut Curie, Orsay, France (I.B., C.N., F.O.); Cancer Imaging Dept, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom (G.J.R.C., V.G., M.M.S.); Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland (A.D.); Laboratory of Medical Information Processing (LaTIM)-team ACTION (image-guided therapeutic action in oncology), INSERM, UMR 1101, IBSAM, UBO, UBL, Brest, France (M.C.D., M.H., T.U.); Department of Radiation Oncology, the Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands (C.V.D.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (S.E., S.N.); Department of Radiation Oncology, Physics Division, University of Michigan, Ann Arbor, Mich (I.E.N., A.U.K.R.); Surgical Planning Laboratory, Brigham and Women's Hospital and Harvard Medical School, Harvard University, Boston, Mass (A.Y.F.); Department of Cancer Imaging and Metabolism, Moffitt Cancer Center, Tampa, Fla (R.J.G.); Department of Medical Image Computing, German Cancer Research Center (DKFZ), Heidelberg, Germany (M. Götz, F.I., K.H.M.H., J.S.); The D-Lab, Department of Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, the Netherlands (P.L., R.T.H.L.); Section for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Germany (F.L., J.S.F., D.T.); Department of Clinical Medicine, University of Bergen, Bergen, Norway (A.L.); Department of Radiation Oncology, University of California, San Francisco, Calif (O.M.); University of Geneva, Geneva, Switzerland (H.M.); Department of Electrical Engineering, Stanford University, Stanford, Calif (S.N.); Department of Medicine (Biomedical Informatics Research), Stanford University School of Medicine, Stanford, Calif (S.N.); Departments of Radiology and Physics, University of British Columbia, Vancouver, Canada (A.R.); Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Mich (A.U.K.R.); Department of Radiation Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, the Netherlands (N.M.S., R.J.H.M.S., L.V.v.D.); School of Engineering, Cardiff University, Cardiff, United Kingdom (E.S., P.W.); Department of Medical Physics, Velindre Cancer Centre, Cardiff, United Kingdom (E.S.); Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany (E.G.C.T., C.R., S. Löck), Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology-OncoRay, Dresden, Germany (E.G.C.T., C.R.); Department of Nuclear Medicine, CHU Milétrie, Poitiers, France (T.U.); Department of Radiology, the Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands (J.v.G.); GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands (J.v.G.); Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (J.v.G.); and Department of Radiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands (F.H.P.v.V.).
Breast
February 2020
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA, Nijmegen, the Netherlands; Department of Radiology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address:
Although computers have had a role in interpretation of mammograms for at least two decades, their impact on performance has not lived up to expectations. However, in the last five years, the field of medical image analysis has undergone a revolution due to the introduction of deep learning convolutional neural networks - a form of artificial intelligence (AI). Because of their considerably higher performance compared to conventional computer aided detection methods, these AI algorithms have resulted in renewed interest in their potential for interpreting breast images in stand-alone mode.
View Article and Find Full Text PDFCancer Discov
April 2020
Dana-Farber Cancer Institute, Boston, Massachusetts.
AKT inhibitors have promising activity in -mutant estrogen receptor (ER)-positive metastatic breast cancer, but the natural history of this rare genomic subtype remains unknown. Utilizing AACR Project GENIE, an international clinicogenomic data-sharing consortium, we conducted a comparative analysis of clinical outcomes of patients with matched -mutant ( = 153) and -wild-type ( = 302) metastatic breast cancer. -mutant cases had similar adjusted overall survival (OS) compared with -wild-type controls (median OS, 24.
View Article and Find Full Text PDFMelanoma Res
June 2020
Departments of Medical Oncology.
Approximately, 50% of patients with uveal melanoma develop distant metastasis for which no standard therapy is established. In contrast to cutaneous melanoma, the anti-CTLA-4 antibody ipilimumab showed no clinical activity in uveal melanoma. Liver directed therapies improve local control, but fail to show overall survival (OS) benefit.
View Article and Find Full Text PDFTrends Cancer
November 2019
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales 2010, Australia. Electronic address:
Cancer-associated fibroblasts (CAFs) are one of the most significant components in the tumour microenvironment (TME), where they can perform several protumourigenic functions. Several studies have recently reported that CAFs are more heterogenous and plastic than was previously thought. As such, there has been a shift in the field to study CAF subpopulations and the emergent functions of these subsets in tumourigenesis.
View Article and Find Full Text PDFRadiother Oncol
March 2020
Maastricht University Medical Centre(+), Department of Radiation Oncology (Maastro Clinic), GROW School of Oncology and Developmental Biology, The Netherlands; KU Leuven, Radiation Oncology, Belgium.
Background And Purpose: The NVALT-11/DLCRG-02 phase III trial (clinicaltrials.gov identifier: NCT01282437) showed that, after standard curative intent treatment, prophylactic cranial irradiation (PCI) decreased the incidence of symptomatic brain metastases (BM) in stage III non-small cell lung cancer (NSCLC) patients compared to observation. In this study we assessed the impact of PCI on health-related quality of life (HRQoL).
View Article and Find Full Text PDFProtein Sci
January 2020
Centre for Molecular and Biomolecular Informatics (CMBI), Radboudumc, Nijmegen, The Netherlands.
We describe a series of databases and tools that directly or indirectly support biomedical research on macromolecules, with focus on their applicability in protein structure bioinformatics research. DSSP, that determines secondary structures of proteins, has been updated to work well with extremely large structures in multiple formats. The PDBREPORT database that lists anomalies in protein structures has been remade to remove many small problems.
View Article and Find Full Text PDFRadiat Oncol
October 2019
Department of Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Background: Thoracic and head and neck cancer radiation therapy (RT) can cause damage to nearby healthy organs such as the esophagus, causing acute radiation-induced esophageal damage (ARIED). A non-invasive method to detect and monitor ARIED can facilitate optimizing RT to avoid ARIED while improving local tumor control. Current clinical guidelines are limited to scoring the esophageal damage based on the symptoms of patients.
View Article and Find Full Text PDFEur J Immunol
January 2020
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Department of Pediatric Immunology, Rheumatology and Infectious diseases, Amsterdam, The Netherlands.
Antibody production by the B cell compartment is a crucial part of the adaptive immune response. Dysregulated antibody production in the form of autoantibodies can cause autoimmune disease. To date, B-cell depletion with anti-CD20 antibodies is commonly applied in autoimmunity, but pre-existing plasma cells are not eliminated in this way.
View Article and Find Full Text PDFActa Oncol
October 2019
Department of Radiation Oncology (Maastro clinic), Maastricht University Medical Center, GROW Research Institute, Maastricht , The Netherlands.
J Immunother
June 2020
Department of Medical Oncology, University Medical Center Groningen, Groningen.
Toxicity of immune checkpoint inhibitors such as ipilimumab and nivolumab is likely associated with clinical efficacy. In this study, we aim to evaluate this association for pembrolizumab. To this end, data of 147 patients included in the Dutch cohort of the Pembrolizumab Expanded Access Program were collected.
View Article and Find Full Text PDFCell
June 2019
Mechanisms of Transcription Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address:
Accurate regulation of mRNA termination is required for correct gene expression. Here, we describe a role for SCAF4 and SCAF8 as anti-terminators, suppressing the use of early, alternative polyadenylation (polyA) sites. The SCAF4/8 proteins bind the hyper-phosphorylated RNAPII C-terminal repeat domain (CTD) phosphorylated on both Ser2 and Ser5 and are detected at early, alternative polyA sites.
View Article and Find Full Text PDF